首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Journal of liver cancer

缩写:

ISSN:2288-8128

e-ISSN:2383-5001

IF/分区:0.0/

文章目录 更多期刊信息

共收录本刊相关文章索引188
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Byeong Geun Song,Myung Ji Goh,Wonseok Kang et al. Byeong Geun Song et al.
Background/aims: Systemic therapy is the current standard treatment for hepatocellular carcinoma (HCC) with extrahepatic metastases (EHM). However, some patients with HCC and EHM undergo transarterial chemoembolization (T...
Anand V Kulkarni,Kumaraswamy P,Balachandran Menon et al. Anand V Kulkarni et al.
Background/aims: Hepatocellular carcinoma (HCC) is generally diagnosed at an advanced stage, which limits curative treatment options for these patients. Locoregional therapy (LRT) is the standard approach to bridge and do...
Jae Hwan Lee,Kun Yung Kim,Chong-Ho Lee et al. Jae Hwan Lee et al.
Background/aim: To evaluate the safety and effectiveness of superselective ablative chemoethanol embolization (SACE) for the treatment of patients with recurrent single hepatocellular carcinoma (rHCC). ...
Jae Seok Bae,Jeong Min Lee,Bo Yun Hur et al. Jae Seok Bae et al.
Background/aims: The enhancing "capsule" (EC) in hepatocellular carcinoma (HCC) diagnosis has received varying degrees of recognition across major guidelines. This study aimed to assess the diagnostic utility of EC in HCC...
Dong Hwan Kim,Sang Hyun Choi Dong Hwan Kim
Backgrounds/aims: To systematically evaluate inter-reader agreement in the assessment of individual Liver Imaging Reporting and Data System (LI-RADS) category M (LR-M) imaging features in computed tomography/magnetic reso...
Jiwon Yang,Won-Mook Choi,Danbi Lee et al. Jiwon Yang et al.
Background: This study aimed to compare the outcomes of liver resection (LR) and transarterial chemoembolization (TACE) in patients with multinodular hepatocellular carcinoma (HCC) within the Milan criteria who were not e...
Bo Hyun Kim,E Hwa Yun,Jeong-Hoon Lee et al. Bo Hyun Kim et al.
Hepatocellular carcinoma (HCC) presents a substantial public health challenge in South Korea as evidenced by 10,565 new cases annually (incidence rate of 30 per 100,000 individuals), in 2020. Cancer registries play a crucial role in gatheri...
Joo Hyun Oh,Dong Hyun Sinn Joo Hyun Oh
Management of hepatocellular carcinoma (HCC) is challenging due to the complex relationship between underlying liver disease, tumor burden, and liver function. HCC is also notorious for its high recurrence rate even after curative treatment...
Dowook Kim,Jun-Sang Kim Dowook Kim
This review examines the transformative role of external beam radiotherapy (EBRT) in managing hepatocellular carcinoma (HCC), spotlighting the progression from traditional EBRT techniques to advanced modalities like intensity-modulated radi...
Do Young Kim Do Young Kim
Approximately 80% of hepatocellular carcinoma (HCC) cases arise in sub-Saharan Africa and Eastern Asia, following a similarly high prevalence of chronic hepatitis B virus (HBV) carriers in these regions. The etiology and epidemiology of HCC...